Skip to main content
SpringerLink
Log in

Are there promising biologic therapies for osteoarthritis?

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

A large unmet need exists for desirable pharmacologic therapeutic interventions for osteoarthritis (OA). Developers of these interventions should be mindful of the current status of therapeutic interventions and focus on the mechanics of the joint and tissues of symptom origin. Much of the pathophysiology of the joint is still poorly understood, particularly as it relates to tissues other than hyaline articular cartilage. Improved knowledge of the role of these tissues (especially bone, fat, and synovium) in OA pathophysiology will likely yield treatment breakthroughs. This review discusses promising biologic therapies for the treatment of OA. Investigators are developing promising therapies, but we need to pay heed to the lessons learned thus far if new therapies are to be effective.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Lawrence RC, Helmick CG, Arnett FC, et al.: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998, 41:778–799. [Comment in: Arthritis Rheum 1999, 42:396.]

    Article  PubMed  CAS  Google Scholar 

  2. Nuki G: Osteoarthritis: a problem of joint failure [review] [in German]. Zeitschrift fur Rheumatologie 1999, 58:142–147.

    Article  PubMed  CAS  Google Scholar 

  3. Eyre DR: Collagens and cartilage matrix homeostasis [review]. Clin Orthop Relat Res 2004, (427 Suppl):S118–S122.

  4. Guccione AA, Felson DT, Anderson JJ, et al.: The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health 1994, 84:351–358.

    PubMed  CAS  Google Scholar 

  5. Hannan MT, Felson DT, Pincus T: Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol 2000, 27:1513–1517.

    PubMed  CAS  Google Scholar 

  6. Felson DT: The sources of pain in knee osteoarthritis [review]. Curr Opin Rheumatol 2005, 17:624–628.

    Article  PubMed  Google Scholar 

  7. Brandt KD, Radin EL, Dieppe PA, van de Putte L: Yet more evidence that osteoarthritis is not a cartilage disease [comment]. Ann Rheum Dis 2006, 65:1261–1264.

    Article  PubMed  CAS  Google Scholar 

  8. Berenbaum F: Signaling transduction: target in osteoarthritis [review]. Curr Opin Rheumatol 2004, 16:616–622.

    Article  PubMed  Google Scholar 

  9. Haringman JJ, Ludikhuize J, Tak PP: Chemokines in joint disease: the key to inflammation? [review]. Ann Rheum Dis 2004, 63:1186–1194.

    Article  PubMed  CAS  Google Scholar 

  10. Fan Z, Chubinskaya S, Rueger DC, et al.: Regulation of anabolic and catabolic gene expression in normal and osteoarthritic adult human articular chondrocytes by osteogenic protein-1. Clin Exp Rheumatol 2004, 22:103–106.

    PubMed  CAS  Google Scholar 

  11. Lajeunesse D: The role of bone in the treatment of osteoarthritis [review]. Osteoarthritis Cartilage 2004, 12(Suppl A):S34–S38.

    Article  PubMed  Google Scholar 

  12. Hill CL, Gale DG, Chaisson CE, et al.: Knee effusions, popliteal cysts, and synovial thickening: association with knee pain in osteoarthritis. J Rheumatol 2001, 28:1330–1337.

    PubMed  CAS  Google Scholar 

  13. Hill CL, Hunter DJ, Niu J, et al.: Changes in synovitis are associated with changes in pain in knee osteoarthritis [abstract]. Arthritis Rheum 2005, 52(9 Suppl):S71.

    Article  Google Scholar 

  14. Bellamy N, Campbell J, Robinson V, et al.: Intraarticular corticosteroid for treatment of osteoarthritis of the knee [review]. Cochrane Database Syst Rev 2005, (2):CD005328.

  15. Mapp PI: Innervation of the synovium [review]. Ann Rheum Dis 1995, 54:398–403.

    PubMed  CAS  Google Scholar 

  16. Safieh-Garabedian B, Poole S, Allchorne A, et al.: Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 1995, 115:1265–1275.

    PubMed  CAS  Google Scholar 

  17. Wieland HA, Michaelis M, Kirschbaum BJ, Rudolphi KA: Osteoarthritis—an untreatable disease? [review]. Nat Rev Drug Discov 2005, 4:331–344. [Erratum appears in Nat Rev Drug Discov 2005, 4:543.]

    Article  PubMed  CAS  Google Scholar 

  18. Chen X, Tanner K, Levine JD: Mechanical sensitization of cutaneous C-fiber nociceptors by prostaglandin E2 in the rat. Neurosci Lett 1999, 267:105–108.

    Article  PubMed  CAS  Google Scholar 

  19. Manning DC, Raja SN, Meyer RA, Campbell JN: Pain and hyperalgesia after intradermal injection of bradykinin in humans. Clin Pharmacol Therap 1991, 50:721–729.

    CAS  Google Scholar 

  20. Flechtenmacher J, Talke M, Veith D, et al.: Bradykinin-receptor-inhibition—a therapeutic option in osteoarthritis [abstract]? Osteoarthritis Cartilage 2004, 12(Suppl):1002.

    Google Scholar 

  21. Walsh DA: Angiogenesis in osteoarthritis and spondylosis: successful repair with undesirable outcomes [review]. Curr Opin Rheumatol 2004, 16:609–615.

    Article  PubMed  Google Scholar 

  22. Chevalier X, Mugnier B, Bouvenot G: Targeted anti-cytokine therapies for osteoarthritis [review] [in French]. Bull Acad Natl Med 2006, 190:1411–1420.

    PubMed  CAS  Google Scholar 

  23. Burr DB: Increased biological activity of subchondral mineralized tissues underlies the progressive deterioration of articular cartilage in osteoarthritis [review]. J Rheumatol 2005, 32:1156–1158.

    PubMed  Google Scholar 

  24. Carbone LD, Nevitt MC, Wildy K, et al.: The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 2004, 50:3516–3525.

    Article  PubMed  Google Scholar 

  25. Bingham CO 3rd, Buckland-Wright JC, Garnero P, et al.: Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 2006, 54:3494–3507. [Comment in: Nat Clin Pract Rheumatol 2007, 3:198–199.]

    Article  PubMed  CAS  Google Scholar 

  26. Buckland-Wright JC, Messent EA, Bingham CO 3rd, et al.: A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients. Rheumatology 2007, 46:257–264.

    Article  PubMed  CAS  Google Scholar 

  27. Papaioannou NA, Triantafillopoulos IK, Khaldi L, et al.: Effect of calcitonin in early and late stages of experimentally induced osteoarthritis. A histomorphometric study. Osteoarthritis Cartilage 2007, 15:386–395.

    Article  PubMed  CAS  Google Scholar 

  28. Sandell LJ: Anabolic factors in degenerative joint disease [review]. Curr Drug Targets 2007, 8:359–365.

    Article  PubMed  CAS  Google Scholar 

  29. Uchino M, Izumi T, Tominaga T, et al.: Growth factor expression in the osteophytes of the human femoral head in osteoarthritis. Clin Orthop Relat Res 2000, (377):119–125.

  30. Brandt KD: Osteophytes in osteoarthritis. Clinical aspects. Osteoarthritis Cartilage 1999, 7:334–335.

    Article  PubMed  CAS  Google Scholar 

  31. Bonnet CS, Walsh DA: Osteoarthritis, angiogenesis and inflammation [review]. Rheumatology 2005, 44:7–16.

    Article  PubMed  CAS  Google Scholar 

  32. Simkin PA: Bone pain and pressure in osteoarthritic joints [review]. Novartis Found Symp 277, 260:179–186.

  33. Coggon D, Reading I, Croft P, et al.: Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord 2001, 25:622–627.

    Article  PubMed  CAS  Google Scholar 

  34. Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002, 288:1723–1727. [Comment in: JAMA 2002, 288:1772–1773.]

    Article  PubMed  Google Scholar 

  35. Ogden CL, Carroll MD, Curtin LR, et al.: Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006, 295:1549–1555.

    Article  PubMed  CAS  Google Scholar 

  36. Sharma L, Lou C, Cahue S, Dunlop DD: The mechanism of the effect of obesity in knee osteoarthritis: the mediating role of malalignment. Arthritis Rheumatism 2000, 43:568–575.

    Article  PubMed  CAS  Google Scholar 

  37. Cicuttini FM, Baker JR, Spector TD: The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol 1996, 23:1221–1226.

    PubMed  CAS  Google Scholar 

  38. Sayer AA, Poole J, Cox V, et al.: Weight from birth to 53 years: a longitudinal study of the influence on clinical hand osteoarthritis. Arthritis Rheumatism 2003, 48:1030–1033.

    Article  PubMed  Google Scholar 

  39. Toda Y, Toda T, Takemura S, et al.: Change in body fat, but not body weight or metabolic correlates of obesity, is related to symptomatic relief of obese patients with knee osteoarthritis after a weight control program. J Rheumatol 1998, 25:2181–2186.

    PubMed  CAS  Google Scholar 

  40. Margetic S, Gazzola C, Pegg GG, et al.: Leptin: a review of its peripheral actions and interactions [review]. Int J Obes Relat Metab Disord 2002, 26:1407–1433.

    Article  PubMed  CAS  Google Scholar 

  41. Aspden RM, Scheven BA, Hutchison JD: Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism. Lancet 2001, 357:1118–1120.

    Article  PubMed  CAS  Google Scholar 

  42. Dumond H, Presle N, Terlain B, et al.: Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 2003, 48:3118–3129. [Comment in: Arthritis Rheum 2003, 48:3009–3012.]

    Article  PubMed  CAS  Google Scholar 

  43. Presle N, Pottie P, Dumond H, et al.: Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthritis Cartilage 2006, 14:690–695.

    Article  PubMed  CAS  Google Scholar 

  44. Seedhom BB, Dowson D, Wright V: Proceedings: Functions of the menisci. A preliminary study. Ann Rheum Dis 1974, 33:111.

    Article  PubMed  CAS  Google Scholar 

  45. Verstraete KL, Verdonk R, Lootens T, et al.: Current status and imaging of allograft meniscal transplantation [review]. Eur J Radiol 1997, 26:16–22.

    Article  PubMed  CAS  Google Scholar 

  46. Rudolphi K, Gerwin N, Verzijl N, et al.: Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthritis Cartilage 2003, 11:738–746.

    Article  PubMed  CAS  Google Scholar 

  47. Zhang X, Mao Z, Yu C: Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10. J Orthop Res 2004, 22:742–750.

    Article  PubMed  CAS  Google Scholar 

  48. Brandt KD, Mazzuca SA, Katz BP, et al.: Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum 2005, 52:2015–2025. [Comment in: Arthritis Rheum 2005, 52:1956–1959.]

    Article  PubMed  CAS  Google Scholar 

  49. Salminen-Mankonen HJ, Morko J, Vuorio E: Role of cathepsin K in normal joints and in the development of arthritis [review]. Curr Drug Targets 2007, 8:315–323.

    Article  PubMed  CAS  Google Scholar 

  50. Glasson SS, Askew R, Sheppard B, et al.: Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005, 434:644–648.

    Article  PubMed  CAS  Google Scholar 

  51. Andriacchi TP: Dynamics of knee malalignment [review]. Orthop Clin North Am 1994, 25:395–403.

    PubMed  CAS  Google Scholar 

  52. Schipplein OD, Andriacchi TP: Interaction between active and passive knee stabilizers during level walking. J Orthop Res 1991, 9:113–119.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Research, New England Baptist Hospital, 125 Parker Hill Avenue, Boston, MA, 02120, USA

    David J. Hunter

Authors
  1. David J. Hunter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David J. Hunter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hunter, D.J. Are there promising biologic therapies for osteoarthritis?. Curr Rheumatol Rep 10, 19–25 (2008). https://doi.org/10.1007/s11926-008-0004-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-008-0004-y

Keywords

Search

Navigation